Notification Detail
New Schedule of Fees and Charges of the Food and Drug Administration for Licensing, Registration and Other Authorizations and Regulatory Services, Amending Administrative Order No. 50 s. 2001, "Revised 2001 Schedule of Fees and Charges for the Corresponding Services Rendered by the Bureau of Food and Drugs". (22 page(s), in English)
Reference: G/TBT/N/PHL/232
Date of arrival: 2020 March 24 - Final date for comments:
2020 May 23
Description
: Additional guidelines on the FDA services particularly on fees and charges, validity of License to Operate (LTO), Certificate of Product Registration (CPR), Foreign Good Manufacturing Practice Certificate (FGMP), among others. Provides guidelines on fees and charges on FDA services including those processes/services in issuing licenses and product market authorizations on all health products prior to manufacture, importation, exportation, sale, offering for sale, distribution, transfer, non-consumer use, promotion, advertising, or sponsorship.Objectives
OtherFields of Activity
ToysCosmetics. Toiletries
Pesticides and other agrochemicals
Tobacco, tobacco products and related equipment
Food products in general
Production in the chemical industry
Pharmaceutics in general
Medical equipment
Full notification form text
Full text of the announced text or any other relevant text
Disclaimer: Please note that the information published is not necessarily comprehensive.
In particular, documents of notifications dated before 1 January 2014, and
comments and answers received or sent on TBT notifications before 1 January 2018 are not
publicly available due to data protection requirements. Some comments and answers received or sent after 1 January 2018 may be unavailable also for data protection reasons.